Excess body weight—including overweight and obesity—is a significant risk factor for cancer. Research from the American Cancer Society estimates that it contributes to approximately 5 percent of ...

News 8 is once again honoring Black history by looking at health care and the racial disparities many report facing.

Slides was placed in the Hail Canyon pack in New Mexico in 2023 ... more vibrant because of them. The post A Haven of Hope: The Wolf Conservation Center’s Fight for the Future of Wolves appeared ...

with Smilow Cancer Hospital and Yale Cancer Center, New Haven, Connecticut. “It’s really clear that this is a practice-changing study,” said Kunz. The findings indicate that this approach ...

Chrzanowski, age 35, passed away peacefully on Saturday, Jan. 18, 2025, at Yale Smilow Cancer Center surrounded by his family ... He enjoyed welding, wood working and was an avid New York Yankees fan.

Epstein, a professor of medicine at the University of Rochester Medical Center ... in the New York Medical Journal. Thanks to a revolution in screening tools and treatments, “cancer” now ...

"The number of patients who achieved this pCR improved significantly as a result of nivolumab, an exciting result that points to a new treatment paradigm in this most common type of breast cancer." ...

The new approval positions Enhertu, an antibody-drug conjugate, or ADC, to be used before chemotherapy in people with low HER2-expressing tumors. Until now, Enhertu was available only for people whose ...

WARNING: This story contains content that may not be suitable for some readers. NEW HAVEN, Ind. (WANE) — The investigation started with an email from the Van Wert Police Department warning Allen ...

The hospital includes the Yale New Haven Children’s Hospital, the Smilow Cancer Hospital, and the Yale New Haven Psychiatric Hospital, and is one of the largest hospitals in the country. “We are ...

New Haven’s flagship refugee resettlement agency is hustling to raise millions of emergency dollars after the Trump administration suddenly canceled a contract to help up to 800 families start ...

Leading the charge for the new GSK-Oxford Cancer Immuno-Prevention Programme is Professor Sarah Blagden from the University of Oxford, supported by a substantial £50 million investment from GSK.